Admin
06 March 2023

Sudarshan Pharma Industries Ltd. IPO Date, Allotment, and All Details

Sudarshan Pharma Industries Limited

Incorporated in 2008, Mumbai-based Sudarshan Pharma Industries Limited( SPIL) has a contract manufacturing establishment to source and force general formulations. It's also engaged in import & import conditioning, and stock of specialty chemicals, API( Active Pharmaceutical elements), and interceders. Based on customers' specifications and conditions, they outsource the manufacturing establishment from suppliers in India and abroad.

The general products supplied by the company have a wide operation in makeup, food, pharma, and tenacious industry. The company is affected by a contract manufacturing establishment, force, and outsourcing of drugs and pharma expression to hospitals, NGOs, government, and healthcare institutes. SPIL has 50 pharma phrasings which are supplied under the brand name in the form of tablets, ointment, capsules, and injectables.

For the ethical marketing of pharmaceutical formulations and products under the brand name in Indian and international markets, the company has its own sales force and distribution network in five states. Additionally, it offers services for formulation development, quality control, and customized solutions.

The following are the company's competitive advantages:

1. A Business model that prioritizes customers and orders
2. A variety of product options
3. Arrangements for contract manufacturing facilities
4. Strong sales, marketing, and distribution networks
5. A variety of Business ventures

Financial Performance

Parameter	March 31, 2020 (in Rs. Lakhs)	March 31, 2021 (in Rs. Lakhs)	September 30, 2022 (in Rs. Lakhs)
Total Assets	9,926.02	13,752.18	16,402.22
Total Revenue	19,372.82	35,755.89	19,589.87
Profit After Tax	267.12	530.37	360.70

Objective of Sudarshan Pharma Industries Limited

The primary objective of Sudarshan Pharma Industries Limited IPO is to raise funds for the following purposes:

1. Operating Capital Needs
2. General corporate objectives.

Sudarshan Pharma Industries Limited IPO Details

IPO Date	Mar 09, 2023 to Mar 14, 2023
Allotment	Mar 17, 2023
Listing Date	Mar 22, 2023
Face Value	₹10 Per Equity Share
Issue Price	₹71 - 73 Per Equity Shares
Issue Size	6,862,400 Shares(INR ₹50.10 Crore)
Market Lot (min. Amt.)	1600 Shares (Rs. 1,16,800/-)
Listing on	BSE SME
Lead Manager	Gretex Corportate Services Pvt. Ltd.
Registrar	Kfin Technologies Ltd.

Company Promoters of Sudarshan Pharma Industries Limited

The Promoters of Sudarshan Pharma Industries Limited are:

1. Mr. Hemal Vasantrai Mehta
2. Mr. Sachin Vasantrai Mehta

As per the Draft Red Herring Prospectus (DRHP) filed by the company with SEBI, the promoter group collectively holds 80.28% of the pre-issue paid-up equity share capital of the company. After the IPO, their shareholding in the company will reduce to N/A% of the post-issue paid-up equity share capital.

Read More IPO related blogs - MCON Rasayan India Limited IPO